Follow the people · Insider
Louis Edward Tamayo
Louis Edward Tamayo files insider transactions with the SEC as a chief financial officer of Lexeo Therapeutics (LXEO). We hold 2 disclosed purchases and sales filed since 3 September 2025, 2 of them in the last 90 days.
- Files forLXEO
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure19 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 29 August 2025 — 18 August 2026Chief Financial Officer · Lexeo Therapeutics (LXEO)9 Form 4 lines · source: SEC Form 4
Everything they disclosed
9 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 4,117 shares of Lexeo TherapeuticsSEC Form 419 August 2026Common Stock · traded 18 August 2026 · filed 19 August 2026
- was granted 12,000 shares of Lexeo TherapeuticsSEC Form 41 July 2026Common Stock · traded 29 June 2026 · filed 1 July 2026
- ▼ sold on the open market 4,641 shares of Lexeo TherapeuticsSEC Form 41 July 2026Common Stock · traded 1 July 2026 · filed 1 July 2026
- was granted 44,665 shares of Lexeo TherapeuticsSEC Form 46 February 2026Common Stock · traded 4 February 2026 · filed 6 February 2026
- was granted 226,665 shares of Lexeo Therapeutics (a derivative holding)SEC Form 46 February 2026Stock Option (right to buy) · traded 4 February 2026 · filed 6 February 2026
- was granted 226,665 shares of Lexeo Therapeutics (a derivative holding)SEC Form 46 February 2026Stock Option (right to buy) · traded 4 February 2026 · filed 6 February 2026
- was granted 44,665 shares of Lexeo TherapeuticsSEC Form 46 February 2026Common Stock · traded 4 February 2026 · filed 6 February 2026
- was granted 280,000 shares of Lexeo Therapeutics (a derivative holding)SEC Form 43 September 2025Stock Option (right to buy) · traded 29 August 2025 · filed 3 September 2025
- was granted 45,000 shares of Lexeo TherapeuticsSEC Form 43 September 2025Common Stock · traded 29 August 2025 · filed 3 September 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.